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Membrane adhesion and the formation of
heterogeneities: biology, biophysics, and
biotechnology†
V. D. Gordon,*a T. J. O’Halloranb and O. Shindella
Membrane adhesion is essential to many vital biological processes. Sites of membrane adhesion are often
associated with heterogeneities in the lipid and protein composition of the membrane. These heterogeneities
are thought to play functional roles by facilitating interactions between proteins. However, the causal links
between membrane adhesion and membrane heterogeneities are not known. Here we survey the state of
the field and indicate what we think are understudied areas ripe for development.
Introduction
The close approach and subsequent adherence and fusion of one
membrane with another is a frequent event that underlies the
organization of all eukaryotic cells. Membrane adhesion can be
found in structures that range in scale from the entire plasma
membrane of a 50 micron cell as it adheres to a substratum to
an individual 50 nm secretory vesicle that adheres to a target
organelle in the cell interior. The past decade has led to an
increasing understanding of the heterogeneous arrangement of
lipids and proteins in membranes. Less frequently considered
is how membrane adhesion and heterogeneity influence each
other. Consideration of this interplay can lead to new mechanistic
insights in how cell membranes function and also aid the design
of lipid carriers for delivery of therapeutics.
This Perspective is a review article that considers how
membrane adhesion and membrane heterogeneity interact.
We begin by highlighting cellular events where membrane
adhesion and heterogeneity are key factors in cellular functions.
We then consider how these events are studied in experimental
model membranes where the components can be defined. Finally
while both the specific adhesion of lipid membranes to targets
and the formation of lateral heterogeneities in membranes
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have been advanced as means of making ‘‘smarter,’’ more
responsive membrane-based therapeutics, to our knowledge
these two streams of investigation have not yet been combined.
We conclude with a consideration of how the intersection of
these topics could advance membrane functionality in technol-
ogies for drug delivery and biosensing.
Biology
Cellular adhesion and signaling
Membrane adhesion and heterogeneity is best understood for the
plasma membrane, the outermost membrane composed of lipids
and proteins that encompasses all eukaryotic cells. The plasma
membrane is known to be composed of groupings of specific lipids
and proteins clustered into microdomains. This ordered arrange-
ment of membrane components creates functional membrane
domains specialized for cell substrate and cell–cell interactions.1–7
A specialized microdomain that has received abundant
consideration from both cell biologists and biophysicists is the
raft.8–12 This concentration of specific lipids, largely sphingolipids
and cholesterol, along with particular proteins is thought to provide
a structural basis for biological function by clustering together
specific components for controlled functional interactions.8,9,13–16
From a biophysical perspective, membrane rafts are often thought
of as phase-separated domains or fluctuations in composition
associated with lipid phase separation.16–21
These phase-separated domains play key roles in several
functions of the plasma membrane. Rafts can concentrate and
even order specific proteins suggesting that this microdomain
can regulate protein–protein interactions.22 The capacity of
rafts to organize and thereby confer regulation to proteins
has been shown in living cells where integrins, cell membrane
proteins that function in cell–substrate interactions, can
change conformation to adopt a higher affinity state for their
ligand when in the appropriate lipid microenvironment.23,24
SNARES, proteins that function in the fusion of a vesicle
with a membrane also appear to function within specialized
lipid microenvironments. The association of SNARES in rafts
may control their ability to function in the recognition and
promotion of the fusion of a specific vesicle with its target, the
plasma membrane.25–28
The concept that organization into heterogeneious specialized
microdomains regulate protein function extends beyond rafts. For
example specialized microdomains on the plasma membrane also
play a role in immunological synapses, a structure where two
immune cells interact. Immunological synapses have been shown
to be sites of protein reorganization and clustering that are
associated with the exchange of information between immune
cells.29,30 This organization has important ramifications for the
organism: aging is associated with changes in the lipid composi-
tion and the behavior of lipid rafts in T-cells as well as altered
signaling response; it has been suggested that alterations in lipid
rafts promote immune dysregulation.31
While most examples of functional clustering of lipids and
proteins into heterogeneous microdomains have been studied on
the plasma membrane, the idea that ordered arrays of lipid
microenvironments regulate protein function is probably true
for the rest of the membranes in cells. SNARE proteins function
in the fusion of vesicles with a target membrane at the plasma
membrane, but also at multiple sites of membrane fusion impor-
tant for organelles, including the fusion of ER-derived secretory
vesicles with the cis-Golgi and other membrane fusion events in
the secretory pathway. Thus it is likely that SNARES are similarly
organized and regulated in microdomains in intracellular
organelles. Microdomains of ordered membranes are known to
provide a platform for organizing proteins into step-wise signaling
cascades; organized signaling events occur throughout organelles
in the cell interior. Microdomains on the intracellular membranes
could well regulate the conformation affinity and function of
proteins in intracellular organelles similarly to how they regulate
events on the plasma membrane.
Model systems
It is difficult, and perhaps impossible, to understand how
membrane adhesion and the heterogeneous organization of
membranes influence each other using living systems alone,
because of the multiplicity of biological processes involved.
Despite widespread observation of the importance of membrane
adhesion and heterogeneities, how they are causally linked is
unknown. Indeed, the origins, character, and function of hetero-
geneities in biological membranes independent of adhesion
still have many open associated questions. Reductionist model
systems provide a way around this, by allowing the effects
of one to a few interactions to be carefully characterized. To
better understand these intricate systems, biophysical and bio-
chemical researchers often use model lipid bilayers. Typical
model membranes contain one to a few lipid species and zero
to a few protein or protein-like species, depending on the purpose
of the investigation.
Model systems for membrane adhesion
In Fig. 1 we summarize the effects that adhesion could have
on a simple bilayer membrane. Note that some effects, such as
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adhesion-induced tension, are expected to apply across the
whole membrane, whereas other effects are localized to the
adhering region or even to single proteins. Although there are
exceptions, as a general rule of thumb the more global effects
arise from generic physics and the more localized effects arise
from molecular specificity.
Fig. 1 Effects of adhesion on a spherical membrane. (Tension) The area of membrane adhesion will increase until binding proteins are saturated or the
free energy benefit to forming one more bond is balanced by the free energy penalty for tensing the membrane by the amount necessary to form one
more bond. Assuming constraint on the membrane’s internal volume, this will result in increasing the tension in the membrane. (Altered curvature) For
the case of an initially-spherical membrane adhering to a flat, rigid target, as shown, the membrane curvature in the adhered region will be zero (grey), the
membrane curvature in the non-adhered membrane may decrease or may be essentially unaltered from the initial curvature (black), and the membrane
just off the adhering area will be highly curved (red). Adhesion to non-flat or non-rigid targets can also result in changes in curvature. (Proximity to target)
Many biological membranes and model membranes contain polymers in the bilayer that prevent nonspecific adhesion (not shown). In addition,
membranes are subject to thermally-driven undulations by the same principle as Brownian motion. Both these act to increase the average distance from
the membrane to any adhesion target. Upon adhesion, the proximity to the target is both reduced and stabilized. (Undulation suppression) Thermally-
driven membrane undulations will be suppressed in the adhering region, because adhesion acts to increase the free energy cost for separating the
membrane from the target. (Receptor clustering) If the availability of targets is sufficiently high, and the free energy of binding sufficiently large, the
receptors in the membrane will demix from their initially-isotropic distribution and become clustered at the adhesion site. This will result in the adhering
part of the membrane being enriched in receptors, and the non-adhering part of the membrane being depleted in receptors. (Receptor conformational
change) In biological systems, adhesion to a ligand often induces a change in the receptor that makes it more susceptible to phosphorylation or some
other change on the cytoplasmic side. This is often the basis for signal transduction. It has been speculated that membrane rafts may be stabilized by
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The artificial giant unilamellar vesicle (GUV) has been
widely used to mimic cell membranes. GUVs are typically
5–50 mm in diameter—the size of a typical eukaryotic cell.
Supported lipid bilayers (SLBs) are widely used as targets
for GUV adhesion. Adhesion can be mediated either by non-
specific, generic interactions or by specific protein–protein
binding. It is our view that for model systems to truly yield
insight into the relationship between membrane adhesion,
protein heterogeneities, and lipid heterogeneities, mixed–lipid
membranes near a phase transition should adhere to a target
via proteins or model proteins. A substantial body of work
using GUV and SLB systems with binding proteins, both model
(e.g. biotin–avidin, RGD-capped lipids,32,33 DNA-capped lipids34,35)
and real (e.g. cadherin36), has examined the biophysics underlying
the static stucture and the dynamic distribution and redistribution
of membrane proteins at adhesion sites.37–52
Microscopy techniques suitable for studying specific adhe-
sion in model systems have developed in parallel with experi-
mental models. Reflection interference contrast microscopy
(RICM) has been widely used to study specifically adhering
membranes.33,37–54 RICM uses the lipid membrane as one
reflecting surface of an interferometer and the adhesion target
substrate as the other reflecting surface. This allows RICM to
measure target-membrane separations with a spatial resolution
set by the wavelength of illuminating light. RICM was originally
adapted for imagining lipid membranes53 and has been well
reviewed by earlier writers.41
Epi-fluorescence studies of specific adhesion often rely
on exciting fluorescent dye molecules conjugated to binding
proteins (typically advin) and using this as a way to visualize
the location of binding proteins.37 Total internal reflection
fluorescence microcopy (TIRF) is another fluorescence-based
technique suitable for measuring membrane adhesion.55 TIRF
uses the evanescent wave of a totally-reflected laser beam
to excite fluorophores. Because the evanescent wave decays
exponentially with distance above the reflecting surface, this
provides a sensitive measure of membrane-target separation.
These and other fluorescence-based techniques are reviewed in
detail by Groves et al.56
The literature studying how adhesion processes lead to
heterogeneities in the distribution of binding proteins com-
monly refers to the formation of protein-dense regions at the
adhesion site as ‘‘phase separation’’. This terminology may be
confusing to the reader new to the field, since this is not the
lipid phase separation discussed in the section below. This
field of work has primarily studied the roles of membrane
mechanics, binder density, and adhesion energies, and how
these interplay.33,37–52,57–61
Adhesion statics
Studies using RICM and epi-fluorescence microscopy to mea-
sure model systems consisting of protein-decorated GUVs
adhered to SLBs has revealed that adhesion is mediated by
the formation and growth of adhesion plaques, i.e. regions
where protein binders are dense (biotin–avidin 1–5%37) and
intermembrane distances are small (for biotin–avidin the
intermembrane distance is 1–5 nm,57 and for RGD–integrin
the intermembrane distance is 5–10 nm58). In mature adhered
membranes—membranes whose adhesion zone has stopped
growing—there are two primary regimes characterized by
(1) complete adhesion zones composed of a single uniform
adhesion plaque and (2) incomplete adhesion zones composed
of adhesion plaques coexisting with regions of low binder
density and large intermembrane distances (for biotin–avidin
the intermembrane distance is 10–20 nm37,57). The two regimes
of mature membrane adhesion can be controlled by binder
concentrations. For biotin–neutravidin binding Fenz et al.37
found incomplete adhesion for initial neutravidin concentra-
tions on the SLB less than 1% and complete adhesion for
concentrations greater than 1%.
Membrane adhesion impacts the effective strength of mole-
cular bonds. For biotin–avidin in free solution, the binding
energy is about 35kBT. In incompletely-adhered membranes,
the biotin–avidin binding energy is only about10kBT. A reduction
in the size of the bond energy associated with incorporating the
protein binders into a membrane, compared with free solution, has
also been observed in the intrinsically weaker bonding pair sialyl-
LewisX—E-selectin.39
Adhesion dynamics
The kinetics of growth of adhesion zones give rise to adhesion
dynamics. Puech et al.43 were able to switch between two
growth regimes by varying the initial tension, and thus the
excess membrane area, in GUVs before adhesion. When
initially-tense (tension 105–104 N m1) membranes were
adhered to an SLB via biotin–streptavidin binding, they
nucleated a single adhesion plaque which proceded to a state
of complete adhesion. The radial growth of the adhesion zone
scaled as time0.2 and the growth of adhesion zones stopped
after about 800 s. When initially-floppy vesicles (tension 107–
106 N m1) were adhered under otherwise identical condi-
tions, many adhesion plaques nucleated and then coalesced. In
this case, radial growth of the adhesion zone scaled as time1
and the adhesion zones stopped growing after about 400 s. This
is a striking demonstration that membrane mechanics can
impact the kinetics of adhesion, in addition to the equilibrated
adhered state.
The growth rates of adhesion zones have also been observed
in systems where GUVs containing RGD proteins adhered to
stationary integrins adsorbed onto a glass substrate.58 This
contrasts with the biotin–avidin mediated adhesion discussed
above, in which avidin binders were mobile in the SLB sub-
strate. Boulbich et al.58 found that when the RGD concentra-
tions in the GUVs were low (less than 0.08–0.1 mol%) the radial
growth of the adhesion zone grew as time1/2 and the adhesion
region stopped growing after 1500–2000 s. However, when RGD
concentrations in the GUVs were high (0.2–2 mol%) the radial
growth of the adhesion zone grew as time1 and adhesion
arrested after 30 s. The slow-growth regime was limited by
RGD proteins on the GUV membrane diffusing into the adhe-
sion front on the vesicle while the fast-growth regime was
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of how the chemical properties of the membrane, here in the
form of the chemical potential of the RGD proteins, can impact
the kinetics of adhesion.
In Fig. 2, we summarize the changes in the physics and
chemistry of a lipid bilayer membrane that could arise from the
effects of adhesion described in Fig. 1.
Fig. 2 Impacts of adhesion on membrane chemistry and physics. (Tension) Work by Evan Evans and co-workers has shown that there are two regimes
of membrane tension – a low-tension regime in which tension primarily acts to reduce thermally-driven membrane undulations, and a high-tension
regime in which tension acts to increase the area per lipid. Membrane undulations increase the number of microstates available to any given macroscopic
configurations, and therefore increase membrane entropy. Therefore, suppressing membrane undulations will decrease the membrane’s entropy.
Membrane undulations can also be suppressed directly as a result of adhesion, as indicated in Fig. 1. This will also reduce the membrane’s entropy in the
adhered region. In the high-tension regime, increasing area/lipid is analogous to increasing volume/molecule in a gas or liquid. It increases the
membrane’s free energy by exposing hydrophobic lipid tails to water. (Altered curvature) The greatest change (per unit membrane area) in bending
energy will happen in the rim membrane just off the adhering area. This rim is shown in red. Depending on the curvature of the initial, non-adhered
membrane, the change in curvature from the spherical region (black) to the flat region (grey) may also result in a comparable change in bending energy.
The rim region (red) will have a higher bending energy than the non-adhered, spherical membrane, and the adhered region (grey) will have a lower
bending energy than the non-adhered, spherical membrane. (Proximity to target) Lipid headgroups are either zwitterionic or charged, as are the materials
in their binding environment. This opens up the possibility of electrostatic interactions, the strength of which depends on the distance between
membrane lipids and the target or other objects. For physiological conditions or work done using biological buffers, it is also necessary to account for the
screening of electrostatic interactions that arises from salt concentration. The Bjerrum length gives the lengthscale at which the electrostatic interaction
between two objects is comparable in magnitude to randomizing thermal energies. It depends inversely on the dielectric constant of the medium, which
will be impacted by the number density and valance of salt ions. (Receptor clustering) The chemical potential of a species is determined by both its
number density and its activity, which can be thought of as proportional to its energy level. Here we consider only the effect of concentration. Entropy
maximization requires minimization of chemical potential, such that each species is isotropically distributed and at the same average number density
everywhere in the system. If favourable binding energies cause receptors to concentrate in the adhering area and be depleted in the non-adhering
membrane, the membrane’s entropy will be reduced. Moreover, the receptor concentration will result in an increased chemical potential for the receptor





















































This journal is© the Owner Societies 2015 Phys. Chem. Chem. Phys., 2015, 17, 15522--15533 | 15527
Model systems for lipid phase separation
Biophysical work motivated by the desire to better understand
rafts in the plasma membrane has elucidated the formation of
lipid sub/super-micron sized heterogeneities by lipid phase
separation in artificial and biological membranes.62–73 The
liquid-ordered phase Lo is widely considered as a model phase
for membrane rafts because it is rich in cholesterol and detergent
insoluble lipid species. Model systems for lipid phase separation
are typically ternary, containing a low-melting phospholipid, a
high-melting sphingolipid (or phospholipid), and cholesterol or
another sterol. The phase diagrams of such systems contain a
region where Lo coexists with the fluid-disordered phase, Ld,
which is widely considered as a model phase for the non-raft
portion of the plasma membrane.
Synthetic model membranes are typically made with a well-
defined mixture of lipids and are made at temperatures above
the chain-melting temperature of the highest-melting lipid in
the system. Electroformation is probably the most widely-used
method for forming GUVs, because it produces a high yield
of unilamellar vesicles that are tens of microns in diameter,
and therefore well-sized for study with optical microscopy.74
However, electroformation can change the molecular structure
of the membrane constituents, which in turn can change the
phase behaviour of the system. Moreover, electroformation
does not work well if the membranes are to be formed in a
salt-containing biological buffer or another electrolyte solution.
To circumvent these concerns, rehydration of a dried lipid film
is also sometimes used.74 For visualization of phase separation
using fluorescence microscopy, fluorescent dyes are incorporated
into the membrane at trace amounts (typically 0.1–0.5 mol%).
These dyes are preferentially excluded from or included into the
lipid phases that form, according to the molecular compatibility
of the dye with the lipid phase structure.75
In other studies, researchers have investigated lipid phase
separation in giant plasma membranes vesicles (GPMVs)
harvested from living cells. GPMVs maintain much of the
chemical complexity of living cells. A recent protocol by Sezgin
et al.62 details how to isolate, fluorescently label, and induce
phase separation in GPMVs.
Upon a temperature quench, GUVs and GPMVs can undergo
Ld–Lo phase separation. In their seminal work, Veatch and
Keller experimentally mapped the full three-component phase
diagram for DPPC/DOPC/Chol membranes.72 This work and
other work on other ternary systems73,76 serve as a basic library
for other researchers investigating phase separation in ternary
GUVs. Included in these works are the phase coordinates of the
associated thermodynamic critical points where compositional
fluctuations exist at the submicron scale. Suprisingly, GPMVs
exist near a compositional critical point.18 The submicron
scale of composition fluctuations in GUVs and GPMVs is the
same scale as lipid rafts. This suggests biology may use critical
lipid compositions as a mechanism for small scale membrane
heterogeneity.
The rapidity of the temperature quench that takes membranes
from isotropic Ld to coexisting Ld and Lo can impact the dynamics
of phase separation by changing whether the system is in the
binodal decomposition region, in which there is an energy
barrier to nucleating an ordered domain, or the spinodal decom-
position region, in which there is no energy barrier to ordered-phase
nucleation. In the binodal region, one to a few ordered-phase
domains will nucleate and then grow in size; in the spinodal
region fluctuation-like, small domains of ordered phase will
appear immediately and then grow by coalescence. A quench into
the spinodal region can also result in the formation of a meta-
stable lipid phase, according to the Ostwald Rule of Stages.75
These are examples of controlling the kinetics of lipid phase
separation by controlling the speed of the temperature quench.
Recently, Stanich et al. studied the dynamics of phase separa-
tion in membranes that all underwent a rapid temperature
quench.77 They measured the growth of Lo domains in membranes
near a miscibility boundary for membranes at both critical and
noncritical compositions. They found that in critical membranes
the radius of ordered-phase domains grew as time0.5 while in
noncritical membranes the radius grew as time0.28. This is an
example of controlling the kinetics of lipid phase separation by
controlling the system’s location on a phase diagram.
Membrane mechanics and phase separation
Coarse-grained approximations that treat the membrane as a
continuum are often used to calculate membrane mechanics.
The elastic energy cost to bend a membrane is described by the
Helfrich Hamiltonian.78 This elastic energy cost will depend on
the radius of curvature R and on the bending modulus k
(Fig. 2). The bending modulus is higher for ordered lipid
phases than for disordered lipid phases. In addition, Brochard
et al. describes the energy cost for stretching the membrane.79
Ordered lipid phases lower area/lipid ratios than disordered
lipid phases. Taken together, these findings suggest that alter-
ing membrane mechanics could alter the phase separation
behaviour of membranes.
Recent publications have reported seemingly-contradictory
effects of increasing membrane tension on the Lo–Ld demixing
temperature.21,80,81 Namely, membranes that were tensed by
micropipette aspiration experienced a consequent reduction in
demixing temperature, but membranes that were tensed by
osmotic stress experienced a consequent increase in demixing
temperature. We suggest that these two sets of observations
may not, in fact, contradict each other, but rather correspond
to the two different regimes of membrane tension.82 Lower
tension corresponds to suppressing membrane undulations,
which we expect83 to increase the demixing temperature by
decreasing the system’s entropy. Higher tension increases the
membrane area per lipid, which we expect disfavour ordered-
phase formation and thus decrease the demixing temperature.
Understanding the role of membrane tension in phase separa-
tion is relevant to biology because tension has been suggested
as a possible cause of the apparent size-limitation of phase-
separated domains in living cells.84
Other researchers have studied how altering gross (micron-
scale) curvature affects the spatial segregation of pre-formed
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corrugated solid substrates that had periodically-varying radii
of curvature, and showed that Lo domains segregated to regions
of lower curvature, leaving the higher-curvature regions covered
with the softer Ld phase.
85
In our previous work,83 we suggested that the suppression of
thermally-driven membrane undulations should favour the
formation of ordered phases when the membrane is near a
demixing transition. For typical GUV sizes (10 mm radius), we
estimated that the shift in the free energy of demixing due to
undulation suppression was of the order kBT while the shift in
the free energy of demixing due to gross curvature modulation
was much smaller, of the order 104 kBT.
83 However, the two
effects become comparable when the vesicle’s radius becomes
about 100 nm. This suggests, as Parthasarathy et al. point out,85
that the submicron scale of lipid rafts may make rafts suscep-
tible to curvature modulation of phase separation.
Model systems for lipid phase separation combined with
adhesion
Other researchers have shown that the distribution of molecu-
lar species in adhering membranes can be controlled by
whether binding agents preferentially partition into the Lo or
Ld phases.
86 More recently, Zhao et al. have found that, near a
critical point in the lipid phase diagram, adhesion produces
heterogeneities in membrane components that is specific to
the molecular affinity of the binder-conjugated lipids.87 In our
lab, we have found that adhesion can form dual, simultaneous
heterogeneities that have protein and lipid composition dis-
tinct from each other and from the non-adhered portion of the
membrane.88 We suggest that this likely results from an inter-
play between generic features of adhesion, which will locally
suppress membrane undulations, reduce curvature, and modify
tension, with a specific molecular affinity of protein-conjugated
lipids for one or more components of the lipid membrane and a
disaffinity of the ordered phase structure for protein-conjugated
lipids that causes these lipids to be excluded as impurities.
In addition to the experiments summarized in the previous
paragraph, there are theoretical models examining the effects
of adhesion on lipid phase separation in membranes.89,90
One reason that theory is powerful is that it allows the behavior
of a complex system to be described as a function of only
the salient parameters. Unfortunately, in the case of the inter-
action between adhesion and phase separation, what control-
ling parameters are relevant for specific cases is not known.
What parameters matter is likely to depend sensitively on
details such as the molecular structure of lipid species in the
membrane, the system’s location on its phase diagram, the
molecular structure and mechanical compliance of adhesion-
mediating binding proteins, the topography and compliance of
the target for adhesion, and the mobility of binding proteins in
the membrane and the target.
Fig. 3 summarizes different ways that adhesion could
impact demixing in a mixed–lipid membrane. These ideas are
grounded in fundamental principles of lipid chemistry and
physics and, to some degree, by empirical studies. However, we
emphasize that these ideas are speculative and the degree to
which the described effects will impact specific systems very
much remains to be determined.
Technology
Encapsulation and controlled release of therapeutic agents
In the clinic and home, lipids and lipid-like amphiphiles are
widely used in technologies for controlled encapsulation and
release.91–97 Liposomes can significantly improve circulation
times and can overcome many of the biophysical barriers to
drug uptake and effectiveness. In liposome-based systems,
delivery is often triggered when the membrane phase separates
laterally, into co-existing fluid and solid phases.98 How phase
transitions promote release is not generally understood.
Phases vary in their lipid packing density, and so may have
varying permeability to drugs, or domain boundaries may have
more defects and therefore be more permeable than continuous
regions of any phase.98–102 It has also been proposed that
physiologically-present proteins act at domain boundaries to
disrupt the liposome and increase release.103 These mechanisms
would tend to favour slow, diffusive release, while the disruption
in the membrane inherent to the phase transition itself could
allow a transitory ‘‘burst’’ of release.
Thermally-triggered phase transitions in the membranes of
vesicles delivering drugs to hyperthermic cancer sites104,105
have gone to clinical trials.106 Typically, the targeted site must
be at 43 1C, whereas normal human body temperature is 37 1C.
Since body temperatures above 40 1C can be life-threatening,
induced hyperthermia at the target site must be spatially
minimized and carefully controlled. This has been one of the
significant obstacles to overcome for this type of therapy, and
has limited its application to sites that can withstand elevated
temperature, and where such elevation in temperature can be
restricted to the target area only.
Much work exists to target delivery from membrane-based
encapsulation systems by incorporating specifically-binding pro-
teins into the membrane. Specifically-binding proteins bind to a
particular ligand or target profile. Tumors may be targeted by
EGF,107,108 transferrin and its receptor,109–111 the RGD sequence,112
or the metastasis-associated Eph A2-EphrinA1 pair.113 Other
binders include T cell receptors and their cognate ligands,113
collagen-binding block copolymers114 and peptides,115 artificial
extracellular matrix proteins,116 cadherins,36 and lipids capped
with RGD32,33 or DNA.34,35 To date, systems of specifically-adhering
membranes for drug delivery have not examined the formation
of heterogeneities in the delivering membrane. However, since
membrane adhesion is associated with the formation of hetero-
geneities in protein and lipid composition and phase, we suggest
that there is likely technological potential for membranes
that respond to adhesion by forming heterogeneities without
requiring harmful elevations in temperature.
Biosensing
By containing many signalling molecules, lipid vesicles have
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events into a many-molecule signal. This approach is widely
used in biosensors117 in which liposome binding to a specific
region on a strip is controlled by analyte concentration. Sub-
sequent processing, typically involving washing-away or lysis of
liposomes, results in a readable signal. Liposome-based sen-
sors have been used to detect a variety of harmful agents and
disease markers118–144 and often have good sensitivity and easy
readout. Reducing the number of steps involved in a biosensor
assay improves that assay’s efficiency and ease of use. Thus, it
is desirable to have liposomes that respond to binding per se by
some detectable signal. One avenue toward such responsive
liposomes may come from phase separation of bilayer mem-
branes, as in the previous section. Therefore, controlling the
characteristics of adhesion-induced phase separation presents
a possible way to control signal amplification in biosensors.
Fig. 4 summarizes some speculative avenues by which the
release of encapsulated contents might be tuned by changing
either the perimeter/area ratio of ordered phase and/or the time-
scale of lipid phase separation, using some of the biophysical ideas
discussed previously and shown in Fig. 1–3. For ease of reference, a
ESI,† Fig. S1 summarizes the most salient points of Fig. 1–3.
Fig. 4 focuses on cases in which the encapsulating
membrane stays intact, but poration or lysis of the membrane
could also be a good strategy for content release. Lateral
clustering of negative-curvature or fusogenic lipids may favour
membrane poration, lysis, and fusion.145–152
Fig. 3 Potential impact of adhesion on lipid demixing. (Entropy decrease) Systems demix when this will minimize their free energy, F = U  TS. Thus, for
equilibrium physics, the conditions determining whether a membrane will be mixed are demixed are set by a competition between energetic and
entropic terms. We have previously argued that suppressing undulations should act to favour demixing by reducing the entropic cost of demixing to form
a stiffer lipid phase. (Increased area/lipid) By Le Chatelier’s principle, which states that an equilibrated system will respond to an externally-imposed
change in such a way as to oppose the change and achieve a new equilibrium, we expect area/lipid dilation to promote mixing because the area per lipid
is greatest for the fluid-disordered Ld phase, and lower for Lo and other ordered lipid phases. (Altered curvature) Work by others has suggested that
changes in curvature alone could cause the membrane to phase separate and localize stiffer phases in regions of low curvature, and softer phases in
regions of high curvature. (Proximity to target) Minimization of electrostatic energy will sort species of the opposite charge sign to be near the target, and
species of the same charge sign to be away from the target. Dipole interactions could alter the tilt of lipid headgroups. Since different lipid phase
structures have different headgroup tilts, in principle this could favour demixing. (Receptor clustering) If the receptors have a specific affinity for a
particular lipid species, that species could be concentrated in the adhesion region of the membrane. This has recently been shown by Sarah Veatch and
co-workers. (Receptor conformational change) If a receptor undergoes a change upon adhesion that alters its affinity for a particular lipid species, that
could promote demixing on a very local, molecular lengthscale. We note that this effect does not depend on adhesion to a large or solid target, but could
happen even for receptor binding to a small, soluble ligand. Therefore, while it may be challenging to achieve in a model or technological system, this
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Conclusions
The interplay between protein-mediated adhesion and lipid
phase separation is greatly under-studied and ripe for growth.
Extant streams of work that separately examine membrane
physics, protein-mediated adhesion, and lipid phase behavior
have laid a firm foundation for a new research area that synthe-
sizes these streams. A better understanding of how specific
adhesion and lipid phase separation interact has the potential
to advance both biology and technology. Both the generic physics
of a flexible membrane and the specific chemistry and molecular
structure of the protein and lipid species involved are likely to play
important roles, as is the mechanics and molecular specificity of
the target for adhesion. This rich landscape of parameters provides
a biophysical and biochemical rationale for the different types of
membrane heterogeneities found at adhesion sites of biological
membranes. This review has focused primarily on adhesion to
external structures, but the scaffolding cytoskeleton is an internal
structure that also has the potential to impact membrane structure.
Adhesion to a soluble ligand could also produce some of the same
biophysical interactions discussed here.
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